APA (7th ed.) Citation

NS, M., AR, B., R, S., B, P., M, S., L, F., . . . I, G. (2023). Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience. Heliyon, 9(2), e13126. https://doi.org/10.1016/j.heliyon.2023.e13126

Chicago Style (17th ed.) Citation

NS, Moriello, et al. "Casirivimab/imdevimab + Remdesivir in Hospitalized Patients with Severe Covid-19: A Single Centre Experience." Heliyon 9, no. 2 (2023): e13126. https://doi.org/10.1016/j.heliyon.2023.e13126.

MLA (9th ed.) Citation

NS, Moriello, et al. "Casirivimab/imdevimab + Remdesivir in Hospitalized Patients with Severe Covid-19: A Single Centre Experience." Heliyon, vol. 9, no. 2, 2023, p. e13126, https://doi.org/10.1016/j.heliyon.2023.e13126.